XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 26, 2020
Jun. 28, 2019
Cash flow from operating activities:    
Net income $ 2,903 $ 1,575
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 1,641 1,365
Equity-based compensation expense 1,149 693
Deferred income taxes (96) (102)
Deferred compensation benefits 154 (81)
Gain on the sale of property and equipment (826) (2)
Non-taxable life insurance gain (389)  
Changes in assets and liabilities that provide (use) cash, excluding the effects of acquisitions:    
Accounts receivable 10,878 (5,852)
Prepaid and other current assets (302) (1,242)
Other long-term assets (420) (24)
Cash surrender value of life insurance 277 233
Accounts payable (2,867) (2,271)
Accrued compensation 957 2,057
Income taxes payable / receivable 1,422 121
Advance billings on contracts 1,833 (1,544)
Other current liabilities 861 369
Other long-term liabilities 2,464 (432)
Net cash provided by (used in) operating activities 19,639 (5,137)
Cash flow from investing activities:    
Cash paid for acquisitions, net of cash acquired (3,995) (8,457)
Additions to property and equipment (583) (572)
Additions to capitalized software (593) (91)
Proceeds from sale of fixed assets 2,442  
Premiums paid for life insurance 144  
Insurance proceeds 400  
Deferred compensation plan investments, net   (1)
Net cash used in investing activities (2,473) (9,121)
Cash flow from financing activities:    
Proceeds from long-term debt 40,845 97,666
Payments on long-term debt (34,135) (84,334)
Taxes remitted for shares withheld from equity-based compensation transactions (160) (153)
Proceeds from Employee Stock Purchase Plan 63 79
Change in cash overdraft, net (370) 154
Net cash provided by financing activities 6,243 13,412
Effect of exchange rates on cash and cash equivalents 129 (295)
Net increase (decrease) in cash and cash equivalents 23,538 (1,141)
Cash and cash equivalents at beginning of year 10,781 12,431
Cash and cash equivalents at end of quarter $ 34,319 $ 11,290